Sulindac and Epirubicin in Treating Patients With Metastatic Malignant Melanoma

NCT00755976 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

32

Enrollment

NETWORK

Sponsor class

Conditions

Melanoma (Skin)

Interventions

DRUG: epirubicin hydrochloride
DRUG: sulindac
OTHER: immunologic technique

Sponsor

Cancer Trials Ireland